Please login to the form below

Not currently logged in
Email:
Password:

Ashley Communications celebrates 20 years of medical communications

Looks forward with new business wins, including AbbVie and Merck & Co accounts

Ashley CommunicationsBuckinghamshire, UK-based Ashley Communications marked two decades of medical communications consulting at the close of 2016, a year that saw the firm strengthen its position with several new business wins.

The consultancy is set to put its expertise in strategic counsel, digital and patient engagement, clinical trial communications and opinion leader development to use for eight new clients this year.

Among this number are big pharma firms Abbvie, Allergan and Merck & Co, as well as UK-based Abbott Diagnostics, opioid addiction specialist Indivior, Tokyo-based Otsuka, detection and informatics specialist Perkin Elmer and Torax Medical, a gastroenterology-focused firm.

Ashley Communications chairman Chrissie Ashley, said: “Our key objective for 2016 was to broaden our client base and to fully utilise the therapeutic experience we have within our agency.

“We are delighted with the results, which put us in a strong position starting 2017.

“We also believe our partnership with Southwood research, which was announced earlier this year, has contributed to our success by providing a truly combined service that really adds value to the services we offer our clients.”

Article by
Rebecca Clifford

11th January 2017

From: Marketing

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Publicis Resolute

Publicis Life Brands Resolute provides real-life practical solutions to your issues, without fuss or fluff. We are an experienced team...

Latest intelligence

Precision medicine and the changing role of the healthcare professional
The growth of precision medicine introduces a shift away from treating the population as a whole, to treating each patient as an individual. How does this change the role of...
How will Sustainability and Transformation Plans (STPs) change the NHS commissioning landscape?
Sue Thomas and Paul Midgley, of Wilmington Healthcare, take a look at new commissioning structures and what they mean for pharma...
eyeforpharma Barcelona 2017 highlights: Industry at the brink of transformation
Hear what Anthill's delegates reported back from the biggest eyeforpharma Barcelona yet....

Infographics